Navigation Links
MiddleBrook Pharmaceuticals Reports Second Quarter 2008 Results
Date:8/14/2008

5,613,544

Total current liabilities 6,812,932 7,273,296

Warrant liability 7,860,000 2,100,000

Deferred contract revenue 11,625,000 11,625,000

Deferred rent and credit on lease

concession 990,746 1,177,840

Total liabilities 27,288,678 22,176,136

Noncontrolling interest 7,157,781 7,337,811

Commitments and contingencies

Stockholders' equity (deficit):

Preferred stock, undesignated - -

Common stock, par value 560,763 467,488

Capital in excess of par value 210,523,235 189,019,188

Accumulated deficit (212,841,581) (195,334,828)

Accumulated other comprehensive

income 373 -

Total stockholders' equity

(deficit) (1,757,210) (5,848,152)

Total liabilities,

noncontrolling interest and

stockholders' equity (deficit) $32,689,249 $23,665,795

MIDDLEBROOK PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Six Months Ended June 30,

2008 2007

Cash flows from operating activities:

Net loss $(17,506,753) $(23,140,917)

Adjustments to reconcile net income

to net cash in operating

activities:

Loss attributable to

noncontrolling interest (180,030) -

Depreciation and amortization
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
2. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
3. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
4. MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
5. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
6. Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results
7. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
8. MAP Pharmaceuticals Reports Second Quarter of 2008 Financial Results
9. Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
10. ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update
11. Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Alan Mozes HealthDay ... When it comes to emergency room waiting times, patients seeking ... time staring down the clock than those seen at smaller ... of crowding and our ability to provide timely emergency care ... of the authors of the new research, Dr. Renee Hsia, ...
(Date:9/18/2014)... proven it true: exercise is good for you. But ... exercise may have an added benefit for cancer patients ... model of melanoma, found that combining exercise with chemotherapy ... Libonati, an associate professor in the School of Nursing ... Nursing Research, was the senior author on the study, ...
(Date:9/18/2014)... TayganPoint Consulting Group, a leading strategic ... co-founder John Cassimatis was named as one of ... recognizing the region’s top healthcare and life science ... the year. , The Innovation Awards celebrate companies ... to shape the medical industry in Greater Philadelphia ...
(Date:9/18/2014)... Savannah, GA (PRWEB) September 18, 2014 ... awarded the Alex Ormond, Jr. Leadership Award by the ... toward improving healthcare and wellness throughout the nation and ... to receive this award,” said Ben. “The Savannah Science ... for 65 years and multiple generations have gone through ...
(Date:9/18/2014)... group of international scientists have developed a new method ... here . , The Wildlife Conservation Society (WCS)-led research, ... Diseases , describes the use of fecal samples from ... been exposed to the virus. This represents a new ... potentially change the way Ebola virus is studied and ...
Breaking Medicine News(10 mins):Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3
... such as having trouble remembering recent events may indicate ... than typical age-related changes. These findings, which are published ... Society, indicate that primary care clinicians, who are ... about their memory, should be aware that such complaints ...
... SEATTLE The number of cases and deaths from breast ... the developing world where more women are dying at younger ... for Health Metrics and Evaluation (IHME) at the University of ... in just three decades, from 641,000 cases in 1980 to ...
... 14, 2011, advance online edition of the New ... hepatitis C who took a combination medicationa telaprevir-based regimen ... weeks were cured. Usually, the treatment is administered ... treatment is unnecessary, possibly changing the standard of care ...
... , WEDNESDAY, Sept. 14 (HealthDay News) -- How ... much you consume in determining the risk of heart ... binge drinking, defined as having seven drinks a day for two ... increased risk for atherosclerosis or "hardening of the arteries" caused by ...
... Alan Mozes HealthDay Reporter , WEDNESDAY, Sept. ... cluster of factors known as the "metabolic syndrome" could ... obese patients without such factors, new research suggests. ... -- increased blood pressure, higher-than-normal insulin levels, excess body ...
... 14 (HealthDay News) -- Some children are born with natural ... Johns Hopkins University researchers tested the "number sense" of ... tests included having the kids look at groups of ... guess which group had more dots. Kids were also ...
Cached Medicine News:Health News:Some memory complaints in the elderly may be warning signs of cognitive problems 2Health News:More women dying from breast and cervical cancer at a younger age in developing countries 2Health News:More women dying from breast and cervical cancer at a younger age in developing countries 3Health News:Shorter treatment with hepatitis C drug combination may be more beneficial, study shows 2Health News:Drinking Patterns Affect Heart Health, Mouse Study Finds 2Health News:Drinking Patterns Affect Heart Health, Mouse Study Finds 3Health News:Certain Risk Factors Could Spur Heart Failure in Normal-Weight People 2Health News:Certain Risk Factors Could Spur Heart Failure in Normal-Weight People 3Health News:Certain Risk Factors Could Spur Heart Failure in Normal-Weight People 4Health News:Trouble With Math? Blame Your Lack of 'Numbers Sense' 2
(Date:9/18/2014)... Sept. 18, 2014  ADM Tronics Unlimited, Inc. ... Ph.D. to its corporate Advisory Board for business ... at the Harvard Medical School and Visiting Professor ... received his Masters degree in Electronics Engineering and ... University of Bologna. After spending a year as ...
(Date:9/18/2014)... Sept. 18, 2014 MiMedx Group, Inc. ... processor and marketer of patent protected regenerative biomaterials ... today that it has entered into a distribution ... will provide its dehydrated human amnion/chorion membrane ("dHACM") ... exclusively on a private label basis. ...
(Date:9/18/2014)... and PLAINSBORO, N.J. , ... its support of the National Hemophilia Foundation,s (NHF) ... which provides support to people with hemophilia and ... psychosocial challenges that can impede disease management. The ... Communication With Your Provider About Pain , ...
Breaking Medicine Technology:ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 2Novo Nordisk Supports National Hemophilia Foundation Initiative for "Collaborating in Care" Disease Management Program 3
... survival,in the SPARC Phase 3 trial consistently demonstrate ... patients receiving,satraplatin. These analyses included prior Taxotere use,geographies, ... -- The two,major causes of progression in the ... were each associated with a 36%,reduction in relative ...
... co-primary endpoints, Wake After Sleep Onset and Total,Sleep Time, ... met at both doses - Evotec to host a,conference ... today , HAMBURG, Germany | OXFORD, England, June 4, ... top-line,results from its first phase II clinical trial of ...
Cached Medicine Technology:Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4
Fluoroperm 151 lens meets special needs of certain patients who need exceptional oxygen permeability for specific corneal condition or lifestyle requirements....
... Thinsite is designed using sophisticated lathing ... concepts. Thinsite lenses feature a center thickness ... ranges. While all plus powered Thinsite lenses ... over standard designs. The unique design eliminates ...
An easy-to-fit RGP daily wear lens with a unique bi-aspheric back surface design that provides excellent patient comfort and adaptation. Boston Envision contact lenses are an ideal alternative for vi...
Ophthalmic surgery stretcher. Designed for exceptional surgeon access, ideal for either superior or temporal approach....
Medicine Products: